v3.26.1
CONDENSED STATEMENTS OF CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (Unaudited) - USD ($)
$ in Thousands
Total
Initial Public Offering [Member]
Private Placement Offering [Member]
Convertible Preferred Stock [Member]
Common Stock [Member]
Common Stock [Member]
Initial Public Offering [Member]
Common Stock [Member]
Private Placement Offering [Member]
Additional Paid-in Capital [Member]
Additional Paid-in Capital [Member]
Initial Public Offering [Member]
Additional Paid-in Capital [Member]
Private Placement Offering [Member]
Accumulated Other Comprehensive Income (Loss) [Member]
Accumulated Deficit [Member]
Convertible Preferred Stock, beginning balance at Dec. 31, 2024       $ 321,373                
Convertible Preferred Stock, beginning balance (in shares) at Dec. 31, 2024       17,228,954                
Beginning balance at Dec. 31, 2024 $ (245,360)       $ 1     $ 51,311     $ 65 $ (296,737)
Beginning balance (in shares) at Dec. 31, 2024         6,667,793              
Conversion of convertible preferred stock into common stock on initial public offering       $ (321,373)                
Conversion of convertible preferred stock into common stock on initial public offering (in shares)       (17,228,954)                
Ending balance at Mar. 31, 2025 313,752       $ 4     638,901     240 (325,393)
Ending balance (in shares) at Mar. 31, 2025         43,353,890              
Convertible Preferred Stock, beginning balance at Dec. 31, 2024       $ 321,373                
Convertible Preferred Stock, beginning balance (in shares) at Dec. 31, 2024       17,228,954                
Beginning balance at Dec. 31, 2024 (245,360)       $ 1     51,311     65 (296,737)
Beginning balance (in shares) at Dec. 31, 2024         6,667,793              
Conversion of convertible preferred stock into common stock on initial public offering 321,373       $ 2     321,371        
Conversion of convertible preferred stock into common stock on initial public offering (in shares)         19,827,003              
Issuance of common stock in offering, net of underwriting discounts and commissions and offering costs   $ 190,379 $ 15,591     $ 1     $ 190,378 $ 15,591    
Issuance of common stock in offering, net of underwriting discounts and commissions and offering costs (in shares)           12,475,000 1,000,000          
Reclassification of convertible preferred stock and common stock warrants into common stock on initial public offering 57,348             57,348        
Reclassification of convertible preferred stock and common stock warrants into common stock on initial public offering (in shares)         3,369,473              
Vesting of restricted stock units (in shares)         104,490              
Stock option exercises 140             140        
Stock option exercises (in shares)         21,377              
Stock-based compensation expense 7,603             7,603        
Unrealized gain (loss) on short-term investments 84                   84  
Net Income (Loss) (45,525)                     (45,525)
Ending balance at Jun. 30, 2025 301,633       $ 4     643,742     149 (342,262)
Ending balance (in shares) at Jun. 30, 2025         43,465,136              
Beginning balance at Mar. 31, 2025 313,752       $ 4     638,901     240 (325,393)
Beginning balance (in shares) at Mar. 31, 2025         43,353,890              
Vesting of restricted stock units (in shares)         104,490              
Stock option exercises 42             42        
Stock option exercises (in shares)         6,756              
Stock-based compensation expense 4,799             4,799        
Unrealized gain (loss) on short-term investments (91)                   (91)  
Net Income (Loss) (16,869)                     (16,869)
Ending balance at Jun. 30, 2025 301,633       $ 4     643,742     149 (342,262)
Ending balance (in shares) at Jun. 30, 2025         43,465,136              
Beginning balance at Dec. 31, 2025 287,610       $ 4     657,140     403 (369,937)
Beginning balance (in shares) at Dec. 31, 2025         44,360,873              
Vesting of restricted stock units (in shares)         303,628              
Stock option exercises $ 1,197       $ 1     1,196        
Stock option exercises (in shares) 224,900       224,900              
Issuance of common stock for employee stock purchase plan (in shares)         92,205              
Issuance of common stock for employee stock purchase plan $ 1,228             1,228        
Stock-based compensation expense 12,422             12,422        
Unrealized gain (loss) on short-term investments (793)                   (793)  
Net Income (Loss) (45,298)                     (45,298)
Ending balance at Jun. 30, 2026 256,366       $ 5     671,986     (390) (415,235)
Ending balance (in shares) at Jun. 30, 2026         44,981,606              
Beginning balance at Mar. 31, 2026 271,245       $ 5     663,168     (96) (391,832)
Beginning balance (in shares) at Mar. 31, 2026         44,561,695              
Vesting of restricted stock units (in shares)         231,012              
Stock option exercises 574             574        
Stock option exercises (in shares)         96,694              
Issuance of common stock for employee stock purchase plan (in shares)         92,205              
Issuance of common stock for employee stock purchase plan 1,228             1,228        
Stock-based compensation expense 7,016             7,016        
Unrealized gain (loss) on short-term investments (294)                   (294)  
Net Income (Loss) (23,403)                     (23,403)
Ending balance at Jun. 30, 2026 $ 256,366       $ 5     $ 671,986     $ (390) $ (415,235)
Ending balance (in shares) at Jun. 30, 2026         44,981,606